Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett's esophagus after oral administration of aminolevulinic acid

Endoscopy

Volumn 35, Issue 8, 2003, Pages 663-668

  Stepinac, T ^b   Felley, Christian ^a   Jornod, P ^a   Lange, N ^b   Gabrecht, T ^b   Fontolliet, C ^a   Grosjean, P ^a   VanMelle, G ^c   Van Den Bergh, H ^b   Monnier, P ^a   Wagnieres G ^b   Dorta, G ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOTRANSFERASE; ONDANSETRON;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOSCOPY; EPITHELIUM TUMOR; ERYTHEMA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; FATIGUE; FEMALE; FLUORESCENCE; HUMAN; INFLAMMATION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEOPLASM; PHOTOTOXICITY; SIDE EFFECT;

ADMINISTRATION, ORAL; ADULT; AGED; AMINOLEVULINIC ACID; BARRETT ESOPHAGUS; CARCINOMA IN SITU; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PREDICTIVE VALUE OF TESTS; PROTOPORPHYRINS; REPRODUCIBILITY OF RESULTS;

EID: 0042388526     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41514     Document Type: Article

References (37)

1. Spechler SJ. Barrett's esophagus. N Engl J Med 2002; 346: 836-842
2. Spechler SJ. Epidemiology and natural history of gastroesophageal reflux disease. Digestion 1992; 51: 24-29
3. Winters C, Spurling T, Chobanian S et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118-124
4. Drewitz D, Sampliner R, Garewal H. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997; 92: 212-215
5. O'Connor J, Falk G, Richter J. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 1999; 94: 2037-2042
6. Overholt B. Results of photodynamic therapy in Barrett's esophagus: A review. Can J Gastroenterol 1999; 13: 393-396
7. Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterol Clin N Am 1997; 26: 613-634
8. Falk GW. Barrett's esophagus. Gastroenterology 2002; 122: 1569-1591
9. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia - An indication for prophylactic esophagectomy. Ann Surg 1996; 224: 66-71
10. Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 1998; 93: 1028-1032
11. Tytgat GNJ. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value? Endoscopy 1995; 27: 19-26
12. Falk GW, Chittajallu R, Goldblum JR et al. Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology. Gastroenterology 1997; 112: 1787-1797
13. Waxman I. Endosonography in columnar-lined esophagus. Gastroenterol Clin N Am 1997; 26: 607-612
14. Levine MS, Herman JB, Furth EE. Barrett's esophagus and esophageal adenocarcinoma - The scope of the problem. Abdom Imaging 1995; 20: 291-298
15. Canto MIF, Setrakian S, Willis JE et al. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: An in vivo and ex vivo study. Endoscopy 2001; 33: 391-400
16. Peng Q, Berg K, Moan J et al. 5-Aminolevulinic acid-based photodynamic therapy: Principles and experimental research. Photochem Photobiol 1997; 65: 235-251
17. Stepp H, Sroka R, Baumgartner R. Fluorescence endoscopy of gastrointestinal diseases: Basic principles, techniques, and clinical experience. Endoscopy 1998; 30: 379-386
18. Gossner L, Stolte M, Sroka R et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998; 114: 448-455
19. Webber J, Kessel D, Fromm D. Side effects and photosensitization of human tissues after aminolevulinic acid. J Surg Res 1997; 68: 31-37
20. Pech O, Gossner L, May A et al. Management of Barrett's oesophagus, dysplasia and early adenocarcinoma. Best Pract Res Clin Gastroenterol 2001; 15: 267-84
21. Endlicher E, Knuechel R, Hauser T et al. Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulanic acid sensitisation. Gut 2001; 48: 314-349
22. Brand S, Wang TD, Schomacker KT et al. Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Gastrointest Endosc 2002; 56: 479-487
23. Messmann H, Endlicher E, Gelbmann CM et al. Fluorescence endoscopy and photodynamic therapy. Dig Liver Dis 2002; 34: 754-761
24. Mayinger B, Neidhardt S, Reh H et al. Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up of esophageal lesions. Gastrointest Endosc 2001; 54: 572-578
25. Kelty CJ, Brown NJ, Reed MWR et al. The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis. Photochem Photobiol Sci 2002; 1: 158-168
26. Sackmann M. Fluorescence diagnosis in gastrointestinal endoscopy. Endoscopy 2000; 32: 977-985
27. Uehlinger P, Zellweger M, Wagnieres G et al. 5-Aminolevulinic acid and its derivatives: Physical chemical properties and protoporphyrin IX formation in cultured cells. J Photochem Photobiol B 2000; 54: 72-80
28. Lange N, Jichlinski P, Zellweger M et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: A pilot study. Br J Cancer 1999; 80: 185-193
29. Kiesslich R, Jung M. Magnification endoscopy: Does it improve mucosal surface analysis for the diagnosis of gastrointestinal neoplasias? Endoscopy 2002; 34: 819-822
30. Lambert R, Rey JF. Endoscopy and early neoplasia: Better but not the best. Endoscopy 2001; 33: 348-352
31. Koop H. State-of-the-art review. Gastroesophageal reflux disease and Barrett's esophagus. Endoscopy 2002; 34: 97-103
32. Rösch T. DDW Report. Reflux disease and Barrett's esophagus. Endoscopy 2002; 34: 851-859
33. Ito S, Muguruma N, Kusaka Y et al. Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen antibody with an infrared fluorescence endoscope in vitro. Endoscopy 2001; 33: 849-853
34. DaCosta RS, Wilson BC, Marcon NE. New optical technologies for earlier endoscopic diagnosis of pregmalignant gastrointestinal lesions. J Gastroenterol Hepatol 2002; 17: S85-S104
35. Panjehpour M, Overholt BF, VoDinh T et al. Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus. Gastroenterology 1996; 111: 93-101
36. Haringsma J, Tytgat GNJ, Yano H et al. Autofluorescence endoscopy: Feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc 2001; 53: 642-650
37. Haringsma J, Prawirodirdjo W, Tytgat GNJ. Accuracy of fluorescence imaging of dysplasia in Barrett's esophagus. Gastroenterology 1999: 116: G1832